YD Bio outlines 2026 clinical roadmap for eye treatments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to YD Bio outlines 2026 clinical roadmap for eye treatments
(NASDAQ: YDES) Delayed: 5.73 +0.96 (20.13%)
Previous Close $4.77    52 Week High $ 
Open $4.77    52 Week Low $ 
Day High $5.88    P/E N/A 
Day Low $4.55    EPS $ 
Volume 656,417